Entertainment
View All
Season 2 of Task Greenlit; Pennsylvania Commits $49.8 Million to Production
For fans of HBO’s Task, the Brad Ingelsby drama filmed across Delaware County, last week delivered the best kind of news: HBO has officially renewed the series for a second …
Lifestyle
View All
Why Philly Renters With Pets Are Facing a New Reality — and a Growing Price Tag
PHILADELPHIA, PA — As pet ownership surges nationwide, Philadelphia has emerged as one of the Northeast’s most accommodating major cities for renters with pets — but that welcome comes with …
Pennsylvania
View All
Pennsylvania Home Sales Rise as Market Holds Steady Heading Into Fall
LEMOYNE, PA — Pennsylvania’s housing market showed signs of firm stability in October as listings and prices held near September levels, while monthly sales climbed, according to new data from …
National
View All
Medicare Shake-Up: Inside CMS’s Sweeping Plan To Rewrite The Rules For Seniors
WASHINGTON, D.C. — The federal government is quietly preparing one of the most sweeping overhauls of Medicare policy in years, advancing a slate of proposed and final rules that could …
Latest Articles
View All
Medicare Shake-Up: Inside CMS’s Sweeping Plan To Rewrite The Rules For Seniors
WASHINGTON, D.C. — The federal government is quietly preparing one of the most sweeping overhauls of Medicare policy in years, advancing a slate of proposed and final rules that could …
CRISPR Breakthrough Revives Chemo Response in Resistant Lung Tumors, Study Finds
WILMINGTON, DE — A new study from ChristianaCare’s Gene Editing Institute shows that disabling a single gene with CRISPR technology can restore chemotherapy sensitivity in lung cancer, a development researchers …
VA Erases Massive CHAMPVA Backlog in Move Affecting Hundreds of Thousands
WASHINGTON, D.C. — The Department of Veterans Affairs said it has eliminated the entire backlog of CHAMPVA applications, ending years of delays for a program that provides health care coverage …
CRISPR Breakthrough Revives Chemo Response in Lung Cancer Models, CorriXR Reports
NEWARK, DE — CorriXR Therapeutics announced new peer-reviewed findings showing that its CRISPR-based gene-editing approach can resensitize squamous cell lung carcinoma (LUSC) tumors to standard chemotherapy, offering a potential path …
FDA Greenlights First Gene Therapy for Older SMA Patients, Raising Hope Nationwide
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Itvisma, a new adeno-associated virus vector-based gene therapy for spinal muscular atrophy, extending treatment eligibility to adults and children 2 …